Cryoprecipitate is a blood product manufactured by warming frozen plasma. Each 15ml unit contains about 100u of factor VIII, 250mg of fibrinogen, and other clotting factors including IX, VIIa and von Willebrand's factor.
Cryoprecipitate is a human blood component obtained from fresh frozen plasma (FFP) prepared from a unit of whole blood (WB).
One unit of cryoprecipitate derived from a unit of whole blood contains a volume of 10-20 mL, 80-100 units of factor VIII which consists of both the procoagulant activity and the von Willebrand factor, 150-250 mg of fibrinogen, 50-100 units of factor XIII, and 50-60 mg of fibronectin.
In the past, cryoprecipitate rich in factor VIII and von Willebrand factor, was considered the treatment of choice for factor VIII replacement in Hemophilia A and von Willebrand disease.
Feeds |
Contact